FibroGen, Inc. (0IL8.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 07:12PM BST
| Previous close | 1.2196 |
| Open | 1.1600 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's range | 1.0696 - 1.1876 |
| 52-week range | 0.3389 - 20.7950 |
| Volume | |
| Avg. volume | 28,076 |
| Market cap | 770,178 |
| Beta (5Y monthly) | 0.74 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -3.0370 |
| Earnings date | 06 May 2024 - 10 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
ZacksUltragenyx (RARE) Meets Efficacy Goal in Neuro Disease Study
Ultragenyx (RARE) reports positive interim data from the phase I/II study of GTX-102 for Angelman syndrome. However, the stock declines due to safety concerns.
ZacksXilio's (XLO) Shares Surge 79.8% in a Month: Here's Why
Xilio (XLO) rallies 79.8% in a month on an exclusive global licensing agreement with Gilead Sciences to develop XTX301 for advanced solid tumors.
ZacksRallyBio (RLYB) Partners With J&J & Gets $6.6M Funding, Stock Up
RallyBio (RLYB) gains 83% after announcing a collaboration deal with J&J to develop novel therapies to reduce the risk of FNAIT in pregnant women, along with funding of $6.6 million from the latter.
© 2024 Yahoo. All rights reserved.